Sign In
Buy CFMS
$2.26
+0 (+0%)
At Close: Nov 30, 2023
Scaling a Personalized Portfolio: restor3d Completes Key Initiative Following Conformis Acquisition
07:00am, Tuesday, 16'th Jan 2024
DURHAM, N.C.--(BUSINESS WIRE)-- #3DPrinting--On September 5, 2023, restor3d, Inc. finalized its previously announced acquisition of Conformis, Inc. With this merger complete, there is tremendous oppor
restor3d Completes Acquisition of Conformis
08:18am, Tuesday, 05'th Sep 2023
Combination Creates the World's Preeminent Producer of Personalized Orthopedic Medical Devices, with Unmatched Additive Manufacturing Capabilities Combination Creates the World's Preeminent Producer o
Independent Proxy Advisory Firm ISS Recommends Conformis Stockholders Vote “FOR” the Pending Merger with restor3d
04:10pm, Monday, 21'st Aug 2023
BILLERICA, Mass., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS ), a leading medical technology company featuring personalized knee and hip replacement products, announced today that
ConforMIS (CFMS) Reports Q2 Loss, Tops Revenue Estimates
08:13pm, Wednesday, 02'nd Aug 2023
ConforMIS (CFMS) came out with a quarterly loss of $1.78 per share versus the Zacks Consensus Estimate of a loss of $1.32. This compares to loss of $2.25 per share a year ago.
Conformis Reports Second Quarter 2023 Financial Results
05:15pm, Wednesday, 02'nd Aug 2023
BILLERICA, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today fi
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Conformis, I
Shareholder Alert: Ademi LLP investigates whether Conformis, Inc. has obtained a Fair Price in its transaction with restor3d
06:31pm, Friday, 23'rd Jun 2023
MILWAUKEE , June 23, 2023 /PRNewswire/ -- Ademi LLP is investigating Conformis (NASDAQ: CFMS) for possible breaches of fiduciary duty and other violations of law in its transaction with restor3d. Cl
CFMS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Conformis, Inc. Is Fair to Shareholders
09:01am, Friday, 23'rd Jun 2023
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Conformis, Inc. (NASDAQ: CFMS) to restor3d for $2.27 per share in cash is fair to Conform
Conformis stock nearly doubles in active trading after cash buyout deal with Restor3d
06:50am, Friday, 23'rd Jun 2023
Shares of Conformis Inc. CFMS, -2.11% rocketed 90.5% to pace all premarket gainers in active trading Friday, after the orthopedic patient care company announced an agreement to be acquired by Restor3d
Conformis Announces Definitive Agreement to be Acquired by restor3d for a Purchase Price of $2.27 Per Share in Cash
10:05pm, Thursday, 22'nd Jun 2023
Combination creates a leading personalized 3D-printed orthopedic medical device company Combination creates a leading personalized 3D-printed orthopedic medical device company
ConforMIS (CFMS) Reports Q1 Loss, Tops Revenue Estimates
10:40am, Monday, 08'th May 2023
ConforMIS (CFMS) came out with a quarterly loss of $1.32 per share versus the Zacks Consensus Estimate of a loss of $1.56. This compares to loss of $2.25 per share a year ago.
Conformis, Inc. (CFMS) Q1 2023 Earnings Call Transcript
10:15am, Monday, 08'th May 2023
Conformis, Inc. (NASDAQ:CFMS ) Q1 2023 Earnings Conference Call May 8, 2023 8:30 AM ET Company Participants Mark Augusti - President and CEO Bob Howe - CFO and Treasurer Conference Call Participants E
Conformis Reports First Quarter 2023 Financial Results
08:05am, Monday, 08'th May 2023
BILLERICA, Mass., May 08, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today fin
Conformis, Inc. to Announce Financial Results for Its First Quarter on May 8, 2023
04:30pm, Thursday, 13'th Apr 2023
BILLERICA, Mass., April 13, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it w
Conformis Launches Patient Awareness Campaign to Highlight the Benefits of Personalized Knee Replacement Procedures
07:00am, Tuesday, 21'st Mar 2023
The campaign underscores that patients have a choice of implant when undergoing total knee arthroscopy, and that they should advocate for the many benefits of a fully personalized knee The campaign un
